Advanced search
Publication Cover
Journal of Parkinsonism and Restless Legs Syndrome Volume 1, 2011 - Issue
Journal homepage
40
Views
2
CrossRef citations to date
0
Altmetric
Review

Causes of Parkinson’s disease: Literature Review

Hassan Shafique1 Department of Neuroscience, University of Toronto, Toronto, Ontario, CanadaCorrespondence[email protected]
,
Alex Blagrove2 Department of Psychology, University of Toronto, Toronto, Ontario, Canada
,
Angela Chung2 Department of Psychology, University of Toronto, Toronto, Ontario, Canada
&
Raynarth Logendrarajah1 Department of Neuroscience, University of Toronto, Toronto, Ontario, Canada
Pages 5-7 | Published online: 01 Dec 2011

References

  • Lai B, Marion S, Teschke K, Tsui J. Occupational and Environmental Risk Factors for Parkinson's Disease. Parkinsonism & Related Disorders 2002; 8: 297–309.
  • Dick FD, Palma GD, Ahmadi A, et al. Environmental Risk Factors for Parkinson's Disease and Parkinsonism: The Geoparkinson Study. Occupational Environmental Medicine 2007, 64: 666–672.
  • Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental Risk Factors and Parkinson's Disease: A Metaanalysis. Environmental Research Section A 2001; 86: 122–127.
  • Tanner CM, Aston DA. Epidemiology of Parkinson's Disease and Akinetic Syndromes. Current Opinion in Neurology 2000; 13: 427–430.
  • Kurosinski P, Guggisberg M, Götz J. Alzheimer’s and Parkinson’s disease - overlapping or synergistic pathologies? TRENDS in Molecular Medicine 2000; 8(1): 41–43
  • Abramov AY, Gegg M, Grunewald A, Wood NW, Klein C, Schapira AHV. Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease. PLoS ONE 2011; 6(10): 1–9.
  • Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 2003; 26: 81–104.
  • Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson’s disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976; 38: 277–301.
  • Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195–1214
  • Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Apoptosis in Parkinson’s disease: signals for neuronal degradation. Ann Neurol 2003; 53: S61–S72.
  • Nakabeppu Y, K Kajitani, Sakamoto K, Yamaguchi H, Tsuchimoto D. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair 2006; 5: 761–772.
  • Yamaguchi H, Kajitani K, Dan Y, et al. MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Cell Death Differ 2006; 13: 551563.
  • Yoshimura D, Sakumi K, Ohno M, et al. An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. J Biol Chem 2003; 278; 37965–37973.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.